chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Injection site pain, Injection site swelling, Lymphadenopathy, Myalgia
Clinical narrative: Injection Site swelling; Injection site pain; Painful Lymph Node in the left Armpit; Muscle aches; Low fever; General discomfort; All Side Effects listed in the Patient's Fact Sheet; Swollen Lymph Node in the left Armpit; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Mar-2021 and was forwarded to Moderna on 03-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (All Side Effects listed in the Patient's Fact Sheet), PAIN (Painful Lymph Node in the left Armpit) and LYMPHADENOPATHY (Swollen Lymph Node in the left Armpit) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012L20A and 012L20A) for COVID-19 vaccination.     The patient's past medical history included Anxiety since an unknown date, Vitamin B12 deficiency since an unknown date, Insomnia since an unknown date and Hormone replacement therapy. Concurrent medical conditions included Depression (condition was worsening, treatment change to add additional antidepressant). Concomitant products included ALPRAZOLAM from 06-Jun-2011 to an unknown date for Anxiety, CYANOCOBALAMIN from 01-May-2020 to an unknown date for B12 deficiency anaemia, BUPROPION from 21-Feb-2017 to an unknown date for Depression, ZOLPIDEM TARTRATE from 13-Apr-2017 to an unknown date for Insomnia, ESTRADIOL from 10-Dec-2020 to an unknown date for Salpingo-oophorectomy NOS.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021 at 10:40 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Feb-2021, the patient experienced VACCINATION COMPLICATION (All Side Effects listed in the Patient's Fact Sheet) and LYMPHADENOPATHY (Swollen Lymph Node in the left Armpit). On 14-Feb-2021, the patient experienced PAIN (Painful Lymph Node in the left Armpit). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Pain, Injection site pain and Injection site swelling, at an unspecified dose and frequency. On 14-Feb-2021, VACCINATION COMPLICATION (All Side Effects listed in the Patient's Fact Sheet) had not resolved. At the time of the report, PAIN (Painful Lymph Node in the left Armpit) was resolving and LYMPHADENOPATHY (Swollen Lymph Node in the left Armpit) had not resolved.            Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: The additional information document received on 25-MAY-2021. Reporters information is added.  Patient demographic details were added.  First dose information is added. Concomitant drugs were added. Events were added.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, Vaccination complication
Clinical narrative: Injection Site swelling; Injection site pain; Painful Lymph Node in the left Armpit; Muscle aches; Low fever; General discomfort; All Side Effects listed in the Patient's Fact Sheet; Swollen Lymph Node in the left Armpit; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Mar-2021 and was forwarded to Moderna on 03-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (All Side Effects listed in the Patient's Fact Sheet), PAIN (Painful Lymph Node in the left Armpit) and LYMPHADENOPATHY (Swollen Lymph Node in the left Armpit) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012L20A and 012L20A) for COVID-19 vaccination.     The patient's past medical history included Anxiety since an unknown date, Vitamin B12 deficiency since an unknown date, Insomnia since an unknown date and Hormone replacement therapy. Concurrent medical conditions included Depression (condition was worsening, treatment change to add additional antidepressant). Concomitant products included ALPRAZOLAM from 06-Jun-2011 to an unknown date for Anxiety, CYANOCOBALAMIN from 01-May-2020 to an unknown date for B12 deficiency anaemia, BUPROPION from 21-Feb-2017 to an unknown date for Depression, ZOLPIDEM TARTRATE from 13-Apr-2017 to an unknown date for Insomnia, ESTRADIOL from 10-Dec-2020 to an unknown date for Salpingo-oophorectomy NOS.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021 at 10:40 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Feb-2021, the patient experienced VACCINATION COMPLICATION (All Side Effects listed in the Patient's Fact Sheet) and LYMPHADENOPATHY (Swollen Lymph Node in the left Armpit). On 14-Feb-2021, the patient experienced PAIN (Painful Lymph Node in the left Armpit). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Pain, Injection site pain and Injection site swelling, at an unspecified dose and frequency. On 14-Feb-2021, VACCINATION COMPLICATION (All Side Effects listed in the Patient's Fact Sheet) had not resolved. At the time of the report, PAIN (Painful Lymph Node in the left Armpit) was resolving and LYMPHADENOPATHY (Swollen Lymph Node in the left Armpit) had not resolved.            Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: The additional information document received on 25-MAY-2021. Reporters information is added.  Patient demographic details were added.  First dose information is added. Concomitant drugs were added. Events were added.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Diplopia, Visual impairment
Clinical narrative: Her vision went disassociated; Double vision; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Mar-2021 and was forwarded to Moderna on 03-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VISUAL IMPAIRMENT (Her vision went disassociated) and DIPLOPIA (Double vision) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 032L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced VISUAL IMPAIRMENT (Her vision went disassociated) and DIPLOPIA (Double vision). At the time of the report, VISUAL IMPAIRMENT (Her vision went disassociated) and DIPLOPIA (Double vision) outcome was unknown.            Reportedly, the patient was taking unspecified medications for unknown indication concomitantly. She reported that she could not determine which vision was the right vision and she had difficulties putting her glasses back in the case. This lasted about a minute to two minutes
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache
Clinical narrative: Chills; Headache; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Mar-2021 and was forwarded to Moderna on 02-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced CHILLS (Chills) and HEADACHE (Headache). At the time of the report, CHILLS (Chills) and HEADACHE (Headache) outcome was unknown.            Concomitant medications were not reported. treatment details were not reported.   This case was linked to MOD-2021-041137 (Patient Link).
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Rash erythematous, Vaccination site erythema, Vaccination site rash
Clinical narrative: Today it looks worse and redder than it ever did; Rash is not itchy but it is longer and redder up and down then side to side; Arm was red and rash like at the injection site; Arm was red and rash like at the injection site; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Mar-2021 and was forwarded to Moderna on 03-Mar-2021.    This spontaneous case was reported by a health care professional and describes the occurrence of CONDITION AGGRAVATED (Today it looks worse and redder than it ever did), RASH ERYTHEMATOUS (Rash is not itchy but it is longer and redder up and down then side to side), VACCINATION SITE ERYTHEMA (Arm was red and rash like at the injection site) and VACCINATION SITE RASH (Arm was red and rash like at the injection site) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced RASH ERYTHEMATOUS (Rash is not itchy but it is longer and redder up and down then side to side), VACCINATION SITE ERYTHEMA (Arm was red and rash like at the injection site) and VACCINATION SITE RASH (Arm was red and rash like at the injection site). On 02-Mar-2021, the patient experienced CONDITION AGGRAVATED (Today it looks worse and redder than it ever did). At the time of the report, CONDITION AGGRAVATED (Today it looks worse and redder than it ever did), RASH ERYTHEMATOUS (Rash is not itchy but it is longer and redder up and down then side to side), VACCINATION SITE ERYTHEMA (Arm was red and rash like at the injection site) and VACCINATION SITE RASH (Arm was red and rash like at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Follow up received on 30 April 2021 NNI
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Neck pain, Ocular discomfort, Pain in extremity
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm sore), HEADACHE (really bad headache), NECK PAIN (neck ache on left side) and OCULAR DISCOMFORT (right eye feels like there's something in it (like a sty), burns at times) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm sore). On 30-Jan-2021, the patient experienced HEADACHE (really bad headache) and NECK PAIN (neck ache on left side). On 03-Feb-2021, the patient experienced OCULAR DISCOMFORT (right eye feels like there's something in it (like a sty), burns at times). The patient was treated with IBUPROFEN for Adverse event, at a dose of UNK dosage form and CLARITHROMYCIN (CLARITIN [CLARITHROMYCIN]) for Adverse event, at a dose of UNK dosage form. On 22-Jan-2021, PAIN IN EXTREMITY (arm sore) had resolved. On 01-Feb-2021, HEADACHE (really bad headache) and NECK PAIN (neck ache on left side) had resolved. At the time of the report, OCULAR DISCOMFORT (right eye feels like there's something in it (like a sty), burns at times) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. On 10-Feb-2021, the right eye still bothered; mornings were better and nights were worse.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Headache, Nervousness
Clinical narrative: nervousness; anxiety; headaches daily; This spontaneous case was reported by a health care professional and describes the occurrence of HEADACHE (headaches daily), NERVOUSNESS (nervousness) and ANXIETY (anxiety) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042L20A and 027620A) for COVID-19 vaccination.     Concomitant products included MULTIVITAMINS [VITAMINS NOS] for an unknown indication.   On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Feb-2021, the patient experienced HEADACHE (headaches daily), NERVOUSNESS (nervousness) and ANXIETY (anxiety). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of UNK dosage form and ACETYLSALICYLIC ACID, CAFFEINE, PARACETAMOL, SALICYLAMIDE (EXCEDRIN [ACETYLSALICYLIC ACID;CAFFEINE;PARACETAMOL;SALICYLAMIDE]) for Adverse event, at a dose of 1500 mg. At the time of the report, HEADACHE (headaches daily), NERVOUSNESS (nervousness) and ANXIETY (anxiety) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered ANXIETY (anxiety) to be unlikely related. No further causality assessments were provided for HEADACHE (headaches daily) and NERVOUSNESS (nervousness).    The patient had anxiety previously and she did not relate that to the vaccine.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site warmth
Clinical narrative: Slighly warm at injection site; Area around injection site redness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Slighly warm at injection site) and VACCINATION SITE ERYTHEMA (Area around injection site redness) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE SODIUM (LEVOTHYROXIN), METOPROLOL SUCCINATE (TOPROL XL), LOSARTAN POTASSIUM (LOSARTIN), ESOMEPRAZOLE MAGNESIUM (NEXIUM [ESOMEPRAZOLE MAGNESIUM]), ASA, VITAMIN D [VITAMIN D NOS], FISH OIL, ROSUVASTATIN CALCIUM (CRESTOR), TOCOPHERYL ACETATE, UBIDECARENONE (COQ10 [TOCOPHERYL ACETATE;UBIDECARENONE]) and ASCORBIC ACID, BETACAROTENE, COPPER, TOCOFERSOLAN, ZINC (OCUVITE [ASCORBIC ACID;BETACAROTENE;COPPER;TOCOFERSOLAN;ZINC]) for an unknown indication.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Slighly warm at injection site) and VACCINATION SITE ERYTHEMA (Area around injection site redness). At the time of the report, VACCINATION SITE WARMTH (Slighly warm at injection site) and VACCINATION SITE ERYTHEMA (Area around injection site redness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient did not receive any treatment medication. It was reported that the redness was 2 by 2 in area and on 12-Feb-2021 the area was red again but not bright.
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 antibody test negative
Clinical narrative: no antibodies post second dose; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 ANTIBODY TEST NEGATIVE (no antibodies post second dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 ANTIBODY TEST NEGATIVE (no antibodies post second dose). At the time of the report, SARS-COV-2 ANTIBODY TEST NEGATIVE (no antibodies post second dose) outcome was unknown.            Concomitant product use was not provided by the reporter.  Action taken with mRNA-1273 in response to the events was not applicable.  Treatment information was not provided.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Fatigue
Clinical narrative: Dizziness; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness) and FATIGUE (Fatigue) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced DIZZINESS (Dizziness) and FATIGUE (Fatigue). At the time of the report, DIZZINESS (Dizziness) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment included "Tylenol" - Self medicating to try to alleviate symptoms
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dyspnoea, Fatigue, Feeling of body temperature change, Headache
Clinical narrative: "not felt right"; Palpitations; hot and cold spells; intermittent headaches; general fatigue; Shortness of breath; Weakness; hearing is more sensitive; fever for 2.5 days; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever for 2.5 days), MALAISE ("not felt right"), PALPITATIONS (Palpitations), FEELING OF BODY TEMPERATURE CHANGE (hot and cold spells) and HEADACHE (intermittent headaches) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, the patient experienced PYREXIA (fever for 2.5 days), PALPITATIONS (Palpitations), FEELING OF BODY TEMPERATURE CHANGE (hot and cold spells), HEADACHE (intermittent headaches), FATIGUE (general fatigue), DYSPNOEA (Shortness of breath), ASTHENIA (Weakness) and HYPOACUSIS (hearing is more sensitive). On an unknown date, the patient experienced MALAISE ("not felt right"). At the time of the report, PYREXIA (fever for 2.5 days), PALPITATIONS (Palpitations), FEELING OF BODY TEMPERATURE CHANGE (hot and cold spells), HEADACHE (intermittent headaches), FATIGUE (general fatigue), DYSPNOEA (Shortness of breath), ASTHENIA (Weakness) and HYPOACUSIS (hearing is more sensitive) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant information not provided. Treatment information not provided
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoacusis, Malaise, Palpitations, Pyrexia
Clinical narrative: "not felt right"; Palpitations; hot and cold spells; intermittent headaches; general fatigue; Shortness of breath; Weakness; hearing is more sensitive; fever for 2.5 days; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever for 2.5 days), MALAISE ("not felt right"), PALPITATIONS (Palpitations), FEELING OF BODY TEMPERATURE CHANGE (hot and cold spells) and HEADACHE (intermittent headaches) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, the patient experienced PYREXIA (fever for 2.5 days), PALPITATIONS (Palpitations), FEELING OF BODY TEMPERATURE CHANGE (hot and cold spells), HEADACHE (intermittent headaches), FATIGUE (general fatigue), DYSPNOEA (Shortness of breath), ASTHENIA (Weakness) and HYPOACUSIS (hearing is more sensitive). On an unknown date, the patient experienced MALAISE ("not felt right"). At the time of the report, PYREXIA (fever for 2.5 days), PALPITATIONS (Palpitations), FEELING OF BODY TEMPERATURE CHANGE (hot and cold spells), HEADACHE (intermittent headaches), FATIGUE (general fatigue), DYSPNOEA (Shortness of breath), ASTHENIA (Weakness) and HYPOACUSIS (hearing is more sensitive) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant information not provided. Treatment information not provided
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Fatigue, Headache, Illness, Injection site pain
Clinical narrative: his prior tinnitus has got worse after the vaccination; has mild headaches and he never has headaches; fatigue; left pain arm at the injection site; has left side sharped chest pain mostly when he exhales, daily; not been feeling well/not feel like himself,; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (not been feeling well/not feel like himself,), HEADACHE (has mild headaches and he never has headaches), TINNITUS (his prior tinnitus has got worse after the vaccination), CHEST PAIN (has left side sharped chest pain mostly when he exhales, daily) and FATIGUE (fatigue) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Chest pain and Tinnitus since an unknown date.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2021, the patient experienced ILLNESS (not been feeling well/not feel like himself,). On 23-Feb-2021, the patient experienced CHEST PAIN (has left side sharped chest pain mostly when he exhales, daily). On an unknown date, the patient experienced HEADACHE (has mild headaches and he never has headaches), TINNITUS (his prior tinnitus has got worse after the vaccination), FATIGUE (fatigue) and INJECTION SITE PAIN (left pain arm at the injection site). The patient was treated with PARACETAMOL (TYLENOL) for Chest pain, at a dose of UNK UNK, 5 times/wk. At the time of the report, ILLNESS (not been feeling well/not feel like himself,), HEADACHE (has mild headaches and he never has headaches), TINNITUS (his prior tinnitus has got worse after the vaccination), CHEST PAIN (has left side sharped chest pain mostly when he exhales, daily), FATIGUE (fatigue) and INJECTION SITE PAIN (left pain arm at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were provided Treatment information included Tylenol around 5 pills since symptoms started
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: his prior tinnitus has got worse after the vaccination; has mild headaches and he never has headaches; fatigue; left pain arm at the injection site; has left side sharped chest pain mostly when he exhales, daily; not been feeling well/not feel like himself,; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (not been feeling well/not feel like himself,), HEADACHE (has mild headaches and he never has headaches), TINNITUS (his prior tinnitus has got worse after the vaccination), CHEST PAIN (has left side sharped chest pain mostly when he exhales, daily) and FATIGUE (fatigue) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Chest pain and Tinnitus since an unknown date.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Feb-2021, the patient experienced ILLNESS (not been feeling well/not feel like himself,). On 23-Feb-2021, the patient experienced CHEST PAIN (has left side sharped chest pain mostly when he exhales, daily). On an unknown date, the patient experienced HEADACHE (has mild headaches and he never has headaches), TINNITUS (his prior tinnitus has got worse after the vaccination), FATIGUE (fatigue) and INJECTION SITE PAIN (left pain arm at the injection site). The patient was treated with PARACETAMOL (TYLENOL) for Chest pain, at a dose of UNK UNK, 5 times/wk. At the time of the report, ILLNESS (not been feeling well/not feel like himself,), HEADACHE (has mild headaches and he never has headaches), TINNITUS (his prior tinnitus has got worse after the vaccination), CHEST PAIN (has left side sharped chest pain mostly when he exhales, daily), FATIGUE (fatigue) and INJECTION SITE PAIN (left pain arm at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were provided Treatment information included Tylenol around 5 pills since symptoms started
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Injection site erythema, Injection site warmth, Pain in extremity, Pruritus
Clinical narrative: itching; Bright red spot below the injection site (2 by 4 in) which is hot to touch; Bright red spot below the injection site (2 by 4 in) which is hot to touch; Body temperature of 99.0 F; tiredness; SORE ARM; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Mar-2021 and was forwarded to the company on 02-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (SORE ARM), PRURITUS (itching), INJECTION SITE WARMTH (Bright red spot below the injection site (2 by 4 in) which is hot to touch), INJECTION SITE ERYTHEMA (Bright red spot below the injection site (2 by 4 in) which is hot to touch) and PYREXIA (Body temperature of 99.0 F) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced PAIN IN EXTREMITY (SORE ARM), PYREXIA (Body temperature of 99.0 F) and FATIGUE (tiredness). On 27-Feb-2021, the patient experienced PRURITUS (itching), INJECTION SITE WARMTH (Bright red spot below the injection site (2 by 4 in) which is hot to touch) and INJECTION SITE ERYTHEMA (Bright red spot below the injection site (2 by 4 in) which is hot to touch). On 26-Feb-2021, FATIGUE (tiredness) had resolved. On 27-Feb-2021, PAIN IN EXTREMITY (SORE ARM) and PYREXIA (Body temperature of 99.0 F) had resolved. At the time of the report, PRURITUS (itching), INJECTION SITE WARMTH (Bright red spot below the injection site (2 by 4 in) which is hot to touch) and INJECTION SITE ERYTHEMA (Bright red spot below the injection site (2 by 4 in) which is hot to touch) outcome was unknown.            Concomitant medications were not reported. Treatment details were not reported.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: itching; Bright red spot below the injection site (2 by 4 in) which is hot to touch; Bright red spot below the injection site (2 by 4 in) which is hot to touch; Body temperature of 99.0 F; tiredness; SORE ARM; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Mar-2021 and was forwarded to the company on 02-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (SORE ARM), PRURITUS (itching), INJECTION SITE WARMTH (Bright red spot below the injection site (2 by 4 in) which is hot to touch), INJECTION SITE ERYTHEMA (Bright red spot below the injection site (2 by 4 in) which is hot to touch) and PYREXIA (Body temperature of 99.0 F) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced PAIN IN EXTREMITY (SORE ARM), PYREXIA (Body temperature of 99.0 F) and FATIGUE (tiredness). On 27-Feb-2021, the patient experienced PRURITUS (itching), INJECTION SITE WARMTH (Bright red spot below the injection site (2 by 4 in) which is hot to touch) and INJECTION SITE ERYTHEMA (Bright red spot below the injection site (2 by 4 in) which is hot to touch). On 26-Feb-2021, FATIGUE (tiredness) had resolved. On 27-Feb-2021, PAIN IN EXTREMITY (SORE ARM) and PYREXIA (Body temperature of 99.0 F) had resolved. At the time of the report, PRURITUS (itching), INJECTION SITE WARMTH (Bright red spot below the injection site (2 by 4 in) which is hot to touch) and INJECTION SITE ERYTHEMA (Bright red spot below the injection site (2 by 4 in) which is hot to touch) outcome was unknown.            Concomitant medications were not reported. Treatment details were not reported.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Pruritus
Clinical narrative: Arm red; Arm itchy; Arm warm; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Arm red), PRURITUS (Arm itchy) and FEELING HOT (Arm warm) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M029) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (Arm red), PRURITUS (Arm itchy) and FEELING HOT (Arm warm). At the time of the report, ERYTHEMA (Arm red), PRURITUS (Arm itchy) and FEELING HOT (Arm warm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications reported were antibiotic for drug use for unknown indication. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2021: Follow up received on 15-jun-2021 is significant . TCR added event outcome is updated to recovered / resolved.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Peripheral swelling, Pruritus, Rash macular
Clinical narrative: red arm; itchy arm; painful arm; swollen arm; arm blotch; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (red arm), PRURITUS (itchy arm), PAIN IN EXTREMITY (painful arm), PERIPHERAL SWELLING (swollen arm) and RASH MACULAR (arm blotch) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced ERYTHEMA (red arm), PRURITUS (itchy arm), PAIN IN EXTREMITY (painful arm), PERIPHERAL SWELLING (swollen arm) and RASH MACULAR (arm blotch). On 28-Feb-2021, PERIPHERAL SWELLING (swollen arm) and RASH MACULAR (arm blotch) had resolved. At the time of the report, ERYTHEMA (red arm), PRURITUS (itchy arm) and PAIN IN EXTREMITY (painful arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant information not provided. Treatment included Tylenol
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Eye pain, Headache, Pain in extremity
Clinical narrative: right eye hurting; backache; hip ache; very bad headache; lil sore on left arm; This spontaneous case was reported by a consumer and describes the occurrence of EYE PAIN (right eye hurting), BACK PAIN (backache), ARTHRALGIA (hip ache), HEADACHE (very bad headache) and PAIN IN EXTREMITY (lil sore on left arm) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced PAIN IN EXTREMITY (lil sore on left arm). On 11-Feb-2021, the patient experienced EYE PAIN (right eye hurting), BACK PAIN (backache), ARTHRALGIA (hip ache) and HEADACHE (very bad headache). The patient was treated with NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency; ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) at an unspecified dose and frequency and PSEUDOEPHEDRINE at an unspecified dose and frequency. At the time of the report, EYE PAIN (right eye hurting), BACK PAIN (backache), ARTHRALGIA (hip ache), HEADACHE (very bad headache) and PAIN IN EXTREMITY (lil sore on left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant information not provided. Treatment included Aleve, Aspirin, Pseudoephedrine
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pain, Pyrexia
Clinical narrative: chills; Achiness; soreness; fever; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Achiness), PAIN (soreness), PYREXIA (fever) and CHILLS (chills) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 038K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Jan-2021, the patient experienced PYREXIA (fever). On 13-Jan-2021, the patient experienced MYALGIA (Achiness) and PAIN (soreness). On 10-Feb-2021, the patient experienced CHILLS (chills). The patient was treated with IBUPROFEN at an unspecified dose and frequency. On 14-Jan-2021, MYALGIA (Achiness) and PAIN (soreness) had resolved. On 11-Feb-2021, PYREXIA (fever) and CHILLS (chills) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant information not provided. Treatment included Ibuprofen
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: Severe Shakes; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (Severe Shakes) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Feb-2021, the patient experienced TREMOR (Severe Shakes). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) for Tremor, at an unspecified dose and frequency. On 25-Feb-2021, TREMOR (Severe Shakes) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Pregnancy test, Ultrasound scan
Clinical narrative: Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a health care professional and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 34-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included FISH OIL from 12-Feb-2021 to an unknown date and PRENATAL MULTIVITAMIN + DHA from 12-Feb-2021 to an unknown date for an unknown indication.    On 24-Feb-2021 at 9:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was on 17-Dec-2020 and the estimated date of delivery was 23-Sep-2021. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  ninth week of the pregnancy.  At the time of the report, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Jan-2021, Pregnancy test: positive (Positive) Positive. On 12-Feb-2021, Ultrasound scan: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information was not provided.  The patient's positive pregnancy test was on 15-Jan-2021 and estimated date of conception was 23-Sep-2021.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Injection site swelling, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: Headache that could choke a horse; Round raised circle; Red injection site; Itchy injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE SWELLING (Round raised circle), VACCINATION SITE ERYTHEMA (Red injection site), VACCINATION SITE PRURITUS (Itchy injection site) and HEADACHE (Headache that could choke a horse) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced INJECTION SITE SWELLING (Round raised circle), VACCINATION SITE ERYTHEMA (Red injection site) and VACCINATION SITE PRURITUS (Itchy injection site). On 27-Feb-2021, the patient experienced HEADACHE (Headache that could choke a horse). At the time of the report, INJECTION SITE SWELLING (Round raised circle), VACCINATION SITE ERYTHEMA (Red injection site), VACCINATION SITE PRURITUS (Itchy injection site) and HEADACHE (Headache that could choke a horse) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment included Acetaminophen Q6H
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: Chills
Clinical narrative: chills; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatoid arthritis. Concomitant products included CELECOXIB (CELEBREX) for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: Fever 103; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever 103) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 02UM20A) for COVID-19 vaccination.     No medical history was provided by the reporter.    On 27-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Feb-2021, the patient experienced PYREXIA (Fever 103). At the time of the report, PYREXIA (Fever 103) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Feb-2021, Body temperature: 103 (Inconclusive) fever 103.         No concomitant medications were provided.  Action taken with mRNA-1273 in response to the events was not applicable.  Treatment medications were not provided.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Polyuria
Clinical narrative: Dizziness; Extreme tiredness; increased urination; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), FATIGUE (Extreme tiredness) and POLYURIA (increased urination) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included OMEPRAZOLE, ROSUVASTATIN, POTASSIUM CHLORIDE (K-DUR), LOPERAMIDE HYDROCHLORIDE (IMODIUM), ACETYLSALICYLIC ACID (BABY ASPIRIN), VITAMIN B-COMPLEX VITAMIN C, CYANOCOBALAMIN, PYRIDOXINE HYDROCHLORIDE, THIAMINE HYDROCHLORIDE (VITAMIN B 1-6-12), ASCORBIC ACID, ROSA CANINA FRUIT (VITAMIN C & ROSEHIP) and CALTRATE + D PLUS for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced DIZZINESS (Dizziness), FATIGUE (Extreme tiredness) and POLYURIA (increased urination). At the time of the report, DIZZINESS (Dizziness), FATIGUE (Extreme tiredness) and POLYURIA (increased urination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details were not provided.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Gait inability, Influenza like illness, Limb discomfort, Paraesthesia, Tremor
Clinical narrative: pins and needles on side of the jab; mild pressure when lying on that shoulder; Unable to raise myself from bed; trouble getting up and could not raise his body; shakiness; flu like symptoms; This spontaneous case was reported by a physician and describes the occurrence of TREMOR (shakiness), INFLUENZA LIKE ILLNESS (flu like symptoms), GAIT INABILITY (trouble getting up and could not raise his body), PARAESTHESIA (pins and needles on side of the jab) and LIMB DISCOMFORT (mild pressure when lying on that shoulder) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041L20A and 037K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Feb-2021, the patient experienced TREMOR (shakiness) and INFLUENZA LIKE ILLNESS (flu like symptoms). On 09-Feb-2021, the patient experienced GAIT INABILITY (trouble getting up and could not raise his body). On 10-Feb-2021, the patient experienced GAIT INABILITY (Unable to raise myself from bed). On an unknown date, the patient experienced PARAESTHESIA (pins and needles on side of the jab) and LIMB DISCOMFORT (mild pressure when lying on that shoulder). On 10-Feb-2021, GAIT INABILITY (Unable to raise myself from bed) had resolved. At the time of the report, TREMOR (shakiness), INFLUENZA LIKE ILLNESS (flu like symptoms), GAIT INABILITY (trouble getting up and could not raise his body) and LIMB DISCOMFORT (mild pressure when lying on that shoulder) outcome was unknown and PARAESTHESIA (pins and needles on side of the jab) had not resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The Concomitant medication A-RED  per day was started from 2016 via eye route .  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: Follow up received with Updated Patient demographics. Added Concomitant Drug, Added events and outcome of the events.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Headache, Pain in extremity, Pruritus
Clinical narrative: pain on right arm; back of legs is itching/butt is itching; upper torso is blistering/neck is blistering (comes and goes); headaches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain on right arm), PRURITUS (back of legs is itching/butt is itching), BLISTER (upper torso is blistering/neck is blistering (comes and goes)) and HEADACHE (headaches) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     no medical history is provided and concomitant drugs are provided.  Concomitant products included METFORMIN, Generic Crestor and CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced PAIN IN EXTREMITY (pain on right arm), PRURITUS (back of legs is itching/butt is itching), BLISTER (upper torso is blistering/neck is blistering (comes and goes)) and HEADACHE (headaches). At the time of the report, PAIN IN EXTREMITY (pain on right arm), PRURITUS (back of legs is itching/butt is itching), BLISTER (upper torso is blistering/neck is blistering (comes and goes)) and HEADACHE (headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.